CLINICAL_TRIALS
trial_result
· 2024-03-22
Clinical Trial Update: Safety and Bioactivity of AXT107 in Subjects With Diabetic Macular Edema [Phase 1, Phase 2]
Summary
Clinical trial update reports safety and bioactivity data for AXT107 in diabetic macular edema, with the study terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AsclepiX Therapeutics, Inc. | Conditions: Diabetic Macular Edema (DME) | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-03-22